Unverified50% confidenceOpinionExact time
If developers deliver a local AI health application to ordinary users, they still bear the risk brought by erroneous information themselves, and a disclaimer is only a minimal legal-level notice.
1
Sources
50%
Confidence
Long-term
Relevance
10/16/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedFor health AI product development teams, safety evaluation cannot rely only on clinical case libraries and must introduce real conversations with demographic backgrounds; referral mechanisms need to be upgraded from soft prompts to hard rules; and for high-risk intents such as medication, dosage, and self-diagnosis, there should be dedicated protections independent of the general safety layer.72% similarUnverifiedAs generative AI continues to lower the barrier to building applications, non-developer risk will only increase, not decrease.70% similarUnverifiedFor the vast majority of enterprises, the right decision for generative AI development is not simply 'mindlessly calling an API' or 'training a model from scratch', but depends on data sensitivity, risk tolerance and product goals.69% similarUnverifiedIntegrating external AI introduces trade-offs around data privacy and API costs, which conflict with Excalidraw's emphasis on local-first principles.69% similarUnverifiedIn high-risk scenarios (finance, healthcare, infrastructure), fully relying on AI for coding faces institutional barriers due to unclear accountability.69% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1044437API
curl https://kongchang.com/api/v1/knowledge/claims/1044437MCP
get_claim(id=1044437)